863 related articles for article (PubMed ID: 10421406)
61. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients.
Gaudreau A; Hill E; Balfour HH; Erice A; Boivin G
J Infect Dis; 1998 Aug; 178(2):297-303. PubMed ID: 9697707
[TBL] [Abstract][Full Text] [Related]
62. Recurrent aciclovir-resistant herpes simplex in a child with Wiskott-Aldrich syndrome.
Saijo M; Suzutani T; Murono K; Hirano Y; Itoh K
Br J Dermatol; 1998 Aug; 139(2):311-4. PubMed ID: 9767251
[TBL] [Abstract][Full Text] [Related]
63. Analysis of the thymidine kinase of a herpes simplex virus type 1 isolate that exhibits resistance to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Wilber BA; Docherty JJ
J Gen Virol; 1994 Jul; 75 ( Pt 7)():1743-7. PubMed ID: 8021603
[TBL] [Abstract][Full Text] [Related]
64. Intracellular uptake of thymidine and antiherpetic drugs for thymidine kinase-deficient mutants of herpes simplex virus type 1.
Bae PK; Kim JH; Kim HS; Chung IK; Paik SG; Lee CK
Antiviral Res; 2006 Jul; 70(3):93-104. PubMed ID: 16546268
[TBL] [Abstract][Full Text] [Related]
65. Application of next-generation sequencing to detect acyclovir-resistant herpes simplex virus type 1 variants at low frequency in thymidine kinase gene of the isolates recovered from patients with hematopoietic stem cell transplantation.
Fujii H; Kakiuchi S; Tsuji M; Nishimura H; Yoshikawa T; Yamada S; Omura N; Inagaki T; Shibamura M; Harada S; Taniguchi S; Saijo M
J Virol Methods; 2018 Jan; 251():123-128. PubMed ID: 29074089
[TBL] [Abstract][Full Text] [Related]
66. [Acyclovir-resistant herpes simplex virus infections in immunocompromised patients].
Jansen CL; Maris-Tegeler WG; Wertheim-van Dillen PM; Frissen PH; Weiland HT; van der Noordaa J
Ned Tijdschr Geneeskd; 1992 Feb; 136(6):280-4. PubMed ID: 1311058
[TBL] [Abstract][Full Text] [Related]
67. Phenotypic and genotypic acyclovir resistance surveillance of genital herpes simplex virus 2 in South Africa.
Muller EE; Maseko DV; Kularatne RS
Antiviral Res; 2022 Apr; 200():105277. PubMed ID: 35271913
[TBL] [Abstract][Full Text] [Related]
68. Surveillance of herpes simplex virus resistance to antivirals: a 4-year survey.
Burrel S; Aime C; Hermet L; Ait-Arkoub Z; Agut H; Boutolleau D
Antiviral Res; 2013 Nov; 100(2):365-72. PubMed ID: 24075863
[TBL] [Abstract][Full Text] [Related]
69. Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a two-year sensitivity screening survey.
Nugier F; Colin JN; Aymard M; Langlois M
J Med Virol; 1992 Jan; 36(1):1-12. PubMed ID: 1315366
[TBL] [Abstract][Full Text] [Related]
70. Neonatal herpes encephalitis caused by a virologically confirmed acyclovir-resistant herpes simplex virus 1 strain.
Kakiuchi S; Nonoyama S; Wakamatsu H; Kogawa K; Wang L; Kinoshita-Yamaguchi H; Takayama-Ito M; Lim CK; Inoue N; Mizuguchi M; Igarashi T; Saijo M
J Clin Microbiol; 2013 Jan; 51(1):356-9. PubMed ID: 23100343
[TBL] [Abstract][Full Text] [Related]
71. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
Suzuki M; Okuda T; Shiraki K
Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
[TBL] [Abstract][Full Text] [Related]
72. [Sensitivities to other antiviral drugs and thymidine kinase activity of aciclovir-resistant herpes simplex virus type 1].
Nitta K; Shiota H; Naito T; Mimura Y
Nippon Ganka Gakkai Zasshi; 1994 Jun; 98(6):513-9. PubMed ID: 8030564
[TBL] [Abstract][Full Text] [Related]
73. Investigation of aciclovir-resistant herpes simplex virus I infection in a bone marrow transplantation unit: genotyping shows that different strains are involved.
Venard V; Dauendorffer JN; Carret AS; Corsaro D; Edert D; Bordigoni P; Le Faou A
J Hosp Infect; 2001 Mar; 47(3):181-7. PubMed ID: 11247677
[TBL] [Abstract][Full Text] [Related]
74. Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant.
Kokoris MS; Sabo P; Adman ET; Black ME
Gene Ther; 1999 Aug; 6(8):1415-26. PubMed ID: 10467366
[TBL] [Abstract][Full Text] [Related]
75. Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonate.
Oram RJ; Marcellino D; Strauss D; Gustafson E; Talarico CL; Root AK; Sharma PL; Thompson K; Fingeroth JD; Crumpacker C; Herold BC
J Infect Dis; 2000 Apr; 181(4):1458-61. PubMed ID: 10762577
[TBL] [Abstract][Full Text] [Related]
76. Dendritic keratitis caused by an acyclovir-resistant herpes simplex virus with frameshift mutation.
Zhang W; Suzuki T; Shiraishi A; Shimamura I; Inoue Y; Ohashi Y
Cornea; 2007 Jan; 26(1):105-6. PubMed ID: 17198024
[TBL] [Abstract][Full Text] [Related]
77. Efficacy of anise oil, dwarf-pine oil and chamomile oil against thymidine-kinase-positive and thymidine-kinase-negative herpesviruses.
Koch C; Reichling J; Kehm R; Sharaf MM; Zentgraf H; Schneele J; Schnitzler P
J Pharm Pharmacol; 2008 Nov; 60(11):1545-50. PubMed ID: 18957177
[TBL] [Abstract][Full Text] [Related]
78. Effect of metal complexes of acyclovir and its acetylated derivative on Herpes simplex virus 1 and Herpes simplex virus 2 replication.
Varadinova T; Vilhelmova N; Badenas F; Terrón A; Fiol J; Garcia-Raso A; Genova P
Acta Virol; 2005; 49(4):251-60. PubMed ID: 16402682
[TBL] [Abstract][Full Text] [Related]
79. Heterogeneity and evolution of thymidine kinase and DNA polymerase mutants of herpes simplex virus type 1: implications for antiviral therapy.
Andrei G; Georgala A; Topalis D; Fiten P; Aoun M; Opdenakker G; Snoeck R
J Infect Dis; 2013 Apr; 207(8):1295-305. PubMed ID: 23315323
[TBL] [Abstract][Full Text] [Related]
80. Analysis of antiviral drug properties of thymidine kinase of herpes B virus using recombinant herpes simplex virus 1.
Nguyen PHA; Fukushi S; Yamada S; Harada S; Yoshikawa T; Kinoshita H; Kawahara M; Ogawa T; Ebihara H; Moi ML; Saijo M
Microbiol Spectr; 2024 Jan; 12(1):e0309123. PubMed ID: 38095468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
